文献速递白血病

与干性相关的miRNA特征可识别儿童急性髓系白血病高危患者

A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia.
PubMed 文献 · Br J Haematol · 2023-03-23

研究评估89种调控干性的miRNA在110例儿童急性白血病患者中的预后价值,鉴定出可区分儿童AML预后极好或极差的24-miRNA特征。该特征在公共数据库独立队列中验证,与白血病干性评分及遗传学相关;联合经典预后因素、pLSC6评分和24-miRNA特征预测总生存和无事件生存的能力高于各变量单独使用。

要点

  • 鉴定出24-miRNA特征可区分儿童AML预后极好与极差患者。
  • 24-miRNA特征与白血病干性评分及患者 underlying 遗传学显著相关。
  • 经典预后因素、pLSC6评分与24-miRNA特征联合预测生存能力高于各变量单独使用。

核心结论

  • 24-miRNA特征提供表观遗传数据,可整合遗传学、MRD和干性相关白血病评分以细化儿童AML风险分层。

研究设计与样本

  • 研究评估89种调控干性的miRNA在110例儿童急性白血病患者中的预后作用,并在基于公共数据库的独立队列中验证结果。

主要发现

  • 鉴定出24-miRNA特征可区分儿童AML预后极好或极差的患者。
  • 24-miRNA特征与白血病干性评分及患者 underlying 遗传学显著相关。
  • 经典预后因素(MRD和遗传学)、pLSC6评分与24-miRNA特征联合预测总生存和无事件生存的能力高于各变量单独使用。

关键数值与推荐

  • 24-miRNA特征与白血病干性评分及患者 underlying 遗传学显著相关。
  • 经典预后因素(MRD和遗传学)、pLSC6评分与24-miRNA特征联合预测总生存和无事件生存的能力高于各变量单独使用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical and biological variables like genetic aberrations at diagnosis and the levels of measurable residual disease (MRD) are the most powerful biomarkers to predict the outcome of paediatric leukaemia. Recently, a model integrating the genetic abnormalities, transcriptional identity, and leukaemia stemness measured as leukaemic stem cell score (pLSC6) has been proposed to identify high-risk paediatric acute myeloid leukaemia (AML) patients. However, the role of epigenetics in defining prognosis still needs to be established. We evaluated the role of 89 miRNAs regulating stemness and their contribution to predicting outcomes in 110 paediatric patients with acute leukaemia. We identified a 24-miRNA signature capable of distinguishing paediatric AML patients with excellent or poor outcomes. We validated these results in an independent cohort using public repository-based data. The 24-miRNA signature was significantly associated with the leukaemic stemness scores and the underlying genetics of patients. Notably, the combination of classical prognostic factors (MRD and genetics), the pLSC6 score and the 24-miRNA signature had a higher capacity to predict the overall and event-free survival than each variable individually. Our 24-miRNA signature provides epigenetic data to integrate into genetics, MRD and stemness-related leukaemic scores to refine risk stratification in paediatric AML patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Esperanza-Cebollada E, Gómez-González S, Perez-Jaume S, et al. A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia. Br J Haematol. 2023. PMID: 36951259. doi:10.1111/bjh.18746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。